Wolfe Research began coverage on shares of Asante Solutions (NASDAQ:PUMP) in a research note issued to investors on Wednesday morning, Marketbeat reports. The brokerage issued an outperform rating on the stock.
PUMP has been the topic of several other research reports. Jefferies Financial Group reissued a buy rating and issued a $20.00 target price on shares of Asante Solutions in a research note on Friday, August 10th. Stifel Nicolaus assumed coverage on Asante Solutions in a research note on Monday, September 10th. They issued a buy rating and a $18.00 target price on the stock. Capital One Financial reissued an overweight rating on shares of Asante Solutions in a research note on Wednesday, August 8th. SunTrust Banks set a $24.00 target price on Asante Solutions and gave the company a buy rating in a research note on Thursday, August 30th. Finally, Royal Bank of Canada reaffirmed a buy rating and set a $19.00 price target on shares of Asante Solutions in a research report on Thursday, August 9th. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock currently has an average rating of Buy and an average price target of $21.42.
NASDAQ:PUMP traded down $0.03 during mid-day trading on Wednesday, hitting $17.30. The company had a trading volume of 1,635,918 shares, compared to its average volume of 1,761,060. Asante Solutions has a fifty-two week low of $13.26 and a fifty-two week high of $22.88.
In other news, Director Spencer D. Armour III sold 22,500 shares of the firm’s stock in a transaction dated Tuesday, October 2nd. The stock was sold at an average price of $17.14, for a total transaction of $385,650.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
A number of institutional investors have recently made changes to their positions in the stock. Argent Capital Management LLC raised its position in Asante Solutions by 1.9% in the 2nd quarter. Argent Capital Management LLC now owns 175,680 shares of the company’s stock valued at $2,755,000 after buying an additional 3,300 shares during the last quarter. Metropolitan Life Insurance Co. NY raised its position in Asante Solutions by 23.1% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 23,615 shares of the company’s stock valued at $370,000 after buying an additional 4,426 shares during the last quarter. Hancock Holding Co. raised its position in Asante Solutions by 1.2% in the 1st quarter. Hancock Holding Co. now owns 520,980 shares of the company’s stock valued at $8,279,000 after buying an additional 6,005 shares during the last quarter. MetLife Investment Advisors LLC raised its position in Asante Solutions by 22.4% in the 2nd quarter. MetLife Investment Advisors LLC now owns 33,439 shares of the company’s stock valued at $524,000 after buying an additional 6,110 shares during the last quarter. Finally, Riverhead Capital Management LLC acquired a new stake in Asante Solutions in the 2nd quarter valued at approximately $152,000.
Asante Solutions Company Profile
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
Read More: What is the NASDAQ Stock Market?
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.